- Home
- ATNM vs TDTH Comparison
ATNM vs TDTH Comparison
Compare ATNM & TDTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- TDTH
- Stock Information
- Founded
- ATNM 2000
- TDTH 2014
- Country
- ATNM United States
- TDTH Singapore
- Employees
- ATNM N/A
- TDTH N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- TDTH
- Sector
- ATNM Health Care
- TDTH
- Exchange
- ATNM Nasdaq
- TDTH NYSE
- Market Cap
- ATNM 51.5M
- TDTH 42.7M
- IPO Year
- ATNM N/A
- TDTH 2024
- Fundamental
- Price
- ATNM $1.54
- TDTH $0.33
- Analyst Decision
- ATNM Strong Buy
- TDTH
- Analyst Count
- ATNM 3
- TDTH 0
- Target Price
- ATNM $4.67
- TDTH N/A
- AVG Volume (30 Days)
- ATNM 229.8K
- TDTH 799.3K
- Earning Date
- ATNM 05-09-2025
- TDTH 06-10-2025
- Dividend Yield
- ATNM N/A
- TDTH N/A
- EPS Growth
- ATNM N/A
- TDTH N/A
- EPS
- ATNM N/A
- TDTH N/A
- Revenue
- ATNM N/A
- TDTH $465,435.00
- Revenue This Year
- ATNM N/A
- TDTH N/A
- Revenue Next Year
- ATNM N/A
- TDTH N/A
- P/E Ratio
- ATNM N/A
- TDTH N/A
- Revenue Growth
- ATNM N/A
- TDTH N/A
- 52 Week Low
- ATNM $1.03
- TDTH $0.20
- 52 Week High
- ATNM $8.64
- TDTH $4.74
- Technical
- Relative Strength Index (RSI)
- ATNM 49.81
- TDTH N/A
- Support Level
- ATNM $1.56
- TDTH N/A
- Resistance Level
- ATNM $1.69
- TDTH N/A
- Average True Range (ATR)
- ATNM 0.11
- TDTH 0.00
- MACD
- ATNM -0.01
- TDTH 0.00
- Stochastic Oscillator
- ATNM 32.18
- TDTH 0.00
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About TDTH TRIDENT DIGITAL TECH HOLDINGS LTD SPON ADS EACH REP 8 ORD CL B
Trident Digital Tech Holdings is principally engaged in the provision of business consulting service and IT customization solutions in the Republic of Singapore.